MORGAN STANLEY - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 28 filers reported holding TENAX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,515
-24.2%
13,600
-0.0%
0.00%
Q3 2022$2,00013,604
+113266.7%
0.00%
Q1 2022$012
+1100.0%
0.00%
Q4 2021$01
-50.0%
0.00%
Q3 2021$0
-100.0%
2
-100.0%
0.00%
Q2 2021$80,00038,650
+1932400.0%
0.00%
Q1 2021$020.0%0.00%
Q4 2020$020.0%0.00%
Q3 2020$020.0%0.00%
Q2 2020$02
+100.0%
0.00%
Q1 2020$01
-98.0%
0.00%
Q4 2019$051
-26.1%
0.00%
Q3 2019$069
-1.4%
0.00%
Q2 2019$070
-5.4%
0.00%
Q1 2019$074
-1.3%
0.00%
Q4 2018$075
-9.6%
0.00%
Q3 2018$083
+66.0%
0.00%
Q2 2018$0500.0%0.00%
Q1 2018$0500.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 43,164$61,0000.02%
FAS Wealth Partners, Inc. 58,576$83,0000.01%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 12,200$17,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,018$7,0000.00%
UBS Group AG 72$00.00%
IFP Advisors, Inc 0$00.00%
Advisor Group, Inc. 3,065$4,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders